What are ABIVAX Société Anonyme's key financial statements?

According to the latest financial statement (Form-10K), ABIVAX Société Anonyme has a total asset of $0, Net loss of $0

What are the key financial ratios for ABVX?

ABIVAX Société Anonyme's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is ABIVAX Société Anonyme's revenue broken down by segment or geography?

Currently ABIVAX Société Anonyme data is not available.

Is ABIVAX Société Anonyme profitable?

no, according to the latest financial statements, ABIVAX Société Anonyme has a net loss of $0

Does ABIVAX Société Anonyme have any liabilities?

no, ABIVAX Société Anonyme has liability of 0

How many outstanding shares for ABIVAX Société Anonyme?

ABIVAX Société Anonyme has a total outstanding shares of 0

ABVX Financials: ABIVAX Société Anonyme AI Analysis



Financials

ABVX Financial

ABIVAX Société Anonyme

$96.15

-1.38%

$-1.34

At close: Jun 29, 16:00:00 GMT-4

$129.43

34.61%

$33.28

Pre-market: Jun 30, 07:49:30 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$97.5

Open

$98.33

Day's Range

$93.06 - $129.43

52 week range

$7.41 - $148.83

Volume

1.3M

Avg.Volume

1.7M

Dividend yield

EPS (TTM)

-5.35

Market Cap

$10.3B

What is Abivax SA?

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 68 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	80	8	55	17	8	16
Research & Development	227	49	99	77	39	81
Operating Expenses	302	56	152	93	47	92
Other Non Operating Income (Expenses)	-34	0	-34	0	0	0
Pretax Income	-378	-48	-229	-100	-52	-94
Income Tax Expense	6	0	5	0	0	0
Net Income	-384	-48	-235	-100	-52	-94
Net Income Growth	68%	-8%	150%	22%	21%	-1%
Shares Outstanding (Diluted)	78.95	78.95	75.64	63.4	63.37	63.17
Shares Change (YoY)	25%	25%	20%	1%	1%	26%
EPS (Diluted)	-4.87	-0.61	-3.11	-1.58	-0.82	-1.49
EPS Growth	34%	-26%	108%	22%	22%	-21%
Free Cash Flow	-170	-47	-90	-32	-33	-69
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-301	-56	-152	-93	-47	-92
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-302	-56	-152	-93	-47	-92
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	-1.58%	0%	-2.18%	0%	0%	0%

ABIVAX Société Anonyme (ABVX) Financial

ABVX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Abivax SA?

ABIVAX Société Anonyme (ABVX) Financial

ABVX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Abivax SA?

ABVX Income

Follow-Up Questions

What are ABIVAX Société Anonyme's key financial statements?

What are the key financial ratios for ABVX?

How is ABIVAX Société Anonyme's revenue broken down by segment or geography?

Is ABIVAX Société Anonyme profitable?

Does ABIVAX Société Anonyme have any liabilities?

How many outstanding shares for ABIVAX Société Anonyme?